Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway.

Laprevotte E, Cochaud S, du Manoir S, Lapierre M, Dejou C, Philippe M, Giustiniani J, Frewer KA, Sanders AJ, Jiang WG, Michaud HA, Colombo PE, Bensussan A, Alberici G, Bastid J, Eliaou JF, Bonnefoy N.

Oncotarget. 2017 Dec 6;8(69):113360-113372. doi: 10.18632/oncotarget.23008. eCollection 2017 Dec 26.

2.

CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression.

Bonnefoy N, Bastid J, Alberici G, Bensussan A, Eliaou JF.

Oncoimmunology. 2015 Feb 3;4(5):e1003015. eCollection 2015 May.

3.

IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells.

Mombelli S, Cochaud S, Merrouche Y, Garbar C, Antonicelli F, Laprevotte E, Alberici G, Bonnefoy N, Eliaou JF, Bastid J, Bensussan A, Giustiniani J.

Sci Rep. 2015 Jul 8;5:11874. doi: 10.1038/srep11874.

4.

Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.

Bastid J, Regairaz A, Bonnefoy N, Déjou C, Giustiniani J, Laheurte C, Cochaud S, Laprevotte E, Funck-Brentano E, Hemon P, Gros L, Bec N, Larroque C, Alberici G, Bensussan A, Eliaou JF.

Cancer Immunol Res. 2015 Mar;3(3):254-65. doi: 10.1158/2326-6066.CIR-14-0018. Epub 2014 Nov 17.

5.

IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.

Cochaud S, Giustiniani J, Thomas C, Laprevotte E, Garbar C, Savoye AM, Curé H, Mascaux C, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A, Bastid J.

Sci Rep. 2013 Dec 9;3:3456. doi: 10.1038/srep03456.

6.

ENTPD1/CD39 is a promising therapeutic target in oncology.

Bastid J, Cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A.

Oncogene. 2013 Apr 4;32(14):1743-51. doi: 10.1038/onc.2012.269. Epub 2012 Jul 2. Review.

PMID:
22751118
7.

Mice Drawer System: phase c/d development and perspective.

Cancedda R, Pignataro S, Alberici G, Tenconi C.

J Gravit Physiol. 2002 Jul;9(1):P337-8.

PMID:
15002603
8.
9.

Evidence for an involvement of the neutrophil integrin lymphocyte function-associated antigen-1 in early failure of heart transplants.

Oubenaissa A, Mouas C, Bourgeois F, Le Deist F, Albérici G, Moalic JM, Menasché P.

Circulation. 1996 Nov 1;94(9 Suppl):II254-9.

PMID:
8901756
10.

A dose-searching trial of an anti-LFA1 monoclonal antibody in first kidney transplant recipients.

Le Mauff B, Le Meur Y, Hourmant M, Debray M, Boeffard F, Alberici G, Soulillou JP, Scherrmann JM.

Kidney Int Suppl. 1996 Jan;53:S44-50.

PMID:
8770990
11.

Evaluation of a new preservation solution: Celsior in the isolated rat lung. Paris-Sud University Lung Transplatation Group.

Reignier J, Mazmanian M, Chapelier A, Alberici G, Ménasché P, Weiss M, Hervé P.

J Heart Lung Transplant. 1995 May-Jun;14(3):601-4.

PMID:
7654745
12.

Anti-LFA-1 adhesion molecule monoclonal antibody in prophylaxis of human kidney allograft rejection.

Le Mauff B, Hourmant M, Le Meur Y, Dantal J, Cantarovich D, Caudrelier P, Alberici G, Soulillou JP.

Transplant Proc. 1995 Feb;27(1):865-6. No abstract available.

PMID:
7879210
13.

Treatment of acute rejection in renal graft recipients by thymoglobuline: a retrospective multicenter analysis.

Bock P, Hobler N, Caudrelier P, Alberici G.

Transplant Proc. 1995 Feb;27(1):1058-9. No abstract available.

PMID:
7878802
14.

Direct assessment of the antioxidant effects of a new heart preservation solution, Celsior. A hemodynamic and electron spin resonance study.

Pietri S, Culcasi M, Albat B, Albérici G, Menasché P.

Transplantation. 1994 Sep 27;58(6):739-42. No abstract available.

PMID:
7940702
15.

Experimental evaluation of Celsior, a new heart preservation solution.

Menasché P, Termignon JL, Pradier F, Grousset C, Mouas C, Alberici G, Weiss M, Piwnica A, Bloch G.

Eur J Cardiothorac Surg. 1994;8(4):207-13.

PMID:
8031565
16.

Efficacy of lactobionate-enriched cardioplegic solution in preserving compliance of cold-stored heart transplants.

Menasché P, Hricak B, Pradier F, Cheav SL, Grousset C, Mouas C, Albérici G, Bloch G, Piwnica A.

J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):1053-61.

PMID:
8312306
17.

Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine.

Steinfels GF, Alberici GP, Tam SW, Cook L.

Neuropsychopharmacology. 1988 Dec;1(4):321-7.

PMID:
2855202
18.

Conjugates of elliptinium acetate with mouse monoclonal anti-alpha-fetoprotein antibodies or Fab fragments: in vitro cytotoxic effects upon human hepatoma cell lines.

Alberici GF, Pallardy M, Manil L, Dessaux JJ, Fournier J, Mondesir JM, Bohuon C, Gros P.

Int J Cancer. 1988 Feb 15;41(2):309-14.

PMID:
2448254
19.

Development of a computerized system for inventory of controlled drug substances.

Schmidt W, Alberici G, Cook L.

NIDA Res Monogr. 1988;81:163-6.

PMID:
3136356
20.

Antibody recognition of substituted ammonium ions. Modulation by the counterion.

Pallardy M, Alberici GF, Goodman A, Bohuon C.

J Immunol Methods. 1987 May 20;99(2):179-83.

PMID:
3584990
21.

Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group.

Motté P, Alberici G, Ait-Abdellah M, Bellet D.

J Immunol. 1987 May 15;138(10):3332-8.

PMID:
2437187
22.
23.

Utilization of synthetic peptides for the study of calcitonin and biosynthetic precursors for calcitonin.

Motté P, Vauzelle P, Alberici G, Ait-Abdellah M, Bohuon C, Bellet D.

Int J Rad Appl Instrum B. 1987;14(4):289-94.

PMID:
3654253
24.

Polyclonal antibodies to elliptinium acetate: structure-activity relationships and comparison with human anti-elliptinium IgM.

Pallardy M, Alberici GF, Dessaux JJ, Bohuon C.

Int J Immunopharmacol. 1987;9(2):151-6.

PMID:
3583508
25.

A radioimmunoassay for the antimalarial drug chloroquine.

Freier C, Alberici G, Turk P, Baud F, Bohuon C.

Clin Chem. 1986 Sep;32(9):1742-5.

26.

Monoclonal antibodies to lipophilic and short-sized haptens: application to the 4-amino-quinoline antimalarial drugs.

Freier C, Alberici GF, Andrieux J, Bohuon C.

Mol Immunol. 1986 Aug;23(8):793-7.

PMID:
3796624
27.

[Effect of chronic chloroquine poisoning on the cardiac binding sites of calcium inhibitors in the rat].

Diouf A, Alberici GF, Bidart JM, Bohuon C.

J Pharmacol. 1986 Jul-Sep;17(3):254-9. French.

PMID:
3025523
28.

Human antibodies to the antineoplastic drug elliptinium: characterization and structure-activity relationships.

Alberici GF, Fellous R, Bidart JM, Troalen F, Mondesir JM, Goodman A, Ho DH, Bohuon C.

J Allergy Clin Immunol. 1986 Apr;77(4):624-30.

PMID:
2420854
29.

Radioiodination of human calcitonin using the Iodogen reagent.

Motté P, Vauzelle P, Alberici GF, Troalen F, Bohuon C, Bellet D.

J Immunol Methods. 1986 Mar 13;87(2):223-7.

PMID:
3950431
30.

Ellipticine derivatives interact with muscarinic receptors.

Alberici GF, Bidart JM, Moingeon P, Pailler S, Mondesir JM, Goodman A, Bohuon C.

Biochem Pharmacol. 1985 May 15;34(10):1701-4.

PMID:
2988555
31.

Drug-induced antibodies during 2-N-methyl-9-hydroxyellipticinium acetate (NSC-264137) treatment: schedule dependency and relationship to hemolysis.

Mondesir JM, Bidart JM, Goodman A, Alberici GF, Caille P, Troalen F, Rouesse J, Bohuon C, Gralla RJ, Einzig AI, et al.

J Clin Oncol. 1985 May;3(5):735-40.

PMID:
3998787
32.

Benzodiazepine receptors on human blood platelets.

Moingeon P, Dessaux JJ, Fellous R, Alberici GF, Bidart JM, Motté P, Bohuon C.

Life Sci. 1984 Nov 12;35(20):2003-9.

PMID:
6092810
33.

In vivo modulation of muscarine receptors in rat brain by acute lead intoxication.

Moingeon P, Bidart JM, Alberici GF, Boudène C, Bohuon C.

Toxicology. 1984 May 14;31(2):135-42.

PMID:
6740690
34.

Inhibition of acetylcholinesterase and cholinesterase by ellipticine derivatives.

Alberici GF, Bidart JM, Moingeon P, Mondesir JM, Bohuon C, De Jager R.

Biochem Pharmacol. 1983 Sep 15;32(18):2837-9. No abstract available.

PMID:
6626256
35.

Characterization of a peripheral-type benzodiazepine binding site on human circulating lymphocytes.

Moingeon P, Bidart JM, Alberici GF, Bohuon C.

Eur J Pharmacol. 1983 Aug 19;92(1-2):147-9.

PMID:
6313383

Supplemental Content

Loading ...
Support Center